iShares U.S. Healthcare ETF IYH

iShares U.S. Healthcare ETF (el Fondo), anteriormente iShares Dow Jones U.S. Healthcare Sector Index Fund (el Fondo) es un fondo cotizado no diversificado. El Fondo busca resultados de inversión que correspondan generalmente al rendimiento del precio y el rendimiento por dividendos, antes de comisiones y gastos, del Dow Jones U.S. Health Care Index (el Índice). El Índice mide el rendimiento del sector de la salud del mercado de valores de Estados Unidos e incluye empresas en los grupos industriales, como equipos y servicios de salud, productos farmacéuticos y biotecnología. El Fondo invierte en una muestra representativa de valores incluidos en el Índice que colectivamente tienen un perfil de inversión similar al Índice. Debido al uso de muestreo representativo, el Fondo puede o no tener todas las acciones que están incluidas en el Índice. El asesor de inversiones del Fondo es BlackRock Fund Advisors (BFA).

Con 14 acciones de IYH (USD 985,66) habrías recibido USD 11,06 en dividendos en los últimos 12 meses.

IYH hizo una división de acciones (split) de 5:1 el 7 de marzo de 2024: cada acción se convirtió en 5. Cambió la cantidad de acciones y su precio, pero no el valor total de la inversión.

• The Motley Fool 22 sept

  Better Healthcare ETF: Invesco's Biotech-Focused IBBQ vs. iShares' Broad IYH

  The Invesco Nasdaq Biotechnology ETF (IBBQ) offers lower costs (0.19% expense ratio) and higher 1-year returns (44.6%), making it suitable for growth-focused investors willing to accept volatility. The iShares U.S. Healthcare ETF (IYH) provides broader diversification across 100 healthcare holdings with higher dividend yield (1.1%) and lower volatility, appealing to conservative investors seeking stability and income.

  

• The Motley Fool 8 sept

  Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

  The article compares two healthcare-focused ETFs from iShares: IHE (Pharmaceuticals ETF) with 55 holdings and IYH (Healthcare ETF) with 100 holdings. While IHE delivered stronger 1-year returns of 50% versus IYH's 27.4%, the article recommends IYH as the better choice due to superior 3- and 5-year performance, greater diversification, and larger asset base of $3.9B. Both funds have identical 0.37% expense ratios.

  

• The Motley Fool 13 ago

  Simplify's PINK or iShares' IYH: Which Healthcare ETF Should Long-Term Investors Choose Right Now?

  Simplify Health Care ETF (PINK) has delivered superior 1-year returns of 42% versus iShares U.S. Healthcare ETF's (IYH) 31.4%, driven by active management focused on healthcare innovation and a charitable mission donating profits to cancer research. However, IYH offers lower costs (0.38% vs 0.51% expense ratio), higher dividend yield (1.1% vs 0.6%), and a proven 25+ year track record, making it the more suitable choice for most long-term conservative investors despite PINK's recent outperformance.

  

• The Motley Fool 1 ago

  Healthcare Stocks Are Having a Good Year. Should You Buy a Fidelity or iShares ETF to Profit?

  The article compares two healthcare-focused ETFs: Fidelity MSCI Health Care Index ETF (FHLC) and iShares U.S. Healthcare ETF (IYH). FHLC is recommended as the better choice due to its significantly lower expense ratio (0.08% vs 0.38%), broader diversification with 334 holdings versus 100, and consistent outperformance across multiple time periods. Over 10 years, a $10,000 investment in FHLC would have yielded approximately $1,900 more than IYH.

  

• Benzinga 9 mar

  AbbVie's Early Obesity Drug Data Shows Up To 10% Weight Loss

  AbbVie reported Phase 1 study results for ABBV-295, a long-acting amylin analog for obesity treatment, showing dose-dependent weight reductions of 7.75% to 9.79% at week 12 with generally mild side effects. Despite positive drug data, AbbVie shares traded lower on Monday amid broader market pressure.